Squarepoint
SRTA

Squarepoint’s Strata Critical Medical Inc SRTA Stock Holding History

Squarepoint’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-92,013
Closed -$443K – 4293
2025
Q4 		$443K Sell
92,013
-297,402
-76% -$1.44M ﹤0.01% 3310
2025
Q3 		$1.97M Buy
389,415
+307,621
+376% +$1.36M ﹤0.01% 2121
2025
Q2 		$330K Buy
81,794
+25,709
+46% +$83.7K ﹤0.01% 3613
2025
Q1 		$153K Buy
56,085
+11,780
+27% +$42.3K ﹤0.01% 4102
2024
Q4 		$188K Buy
44,305
+12,311
+38% +$46.9K ﹤0.01% 4493
2024
Q3 		$94.1K Buy
+31,994
New +$102K ﹤0.01% 3883
2024
Q1 		– Sell
-96,836
Closed -$342K – 4045
2023
Q4 		$342K Buy
96,836
+74,414
+332% +$214K ﹤0.01% 3269
2023
Q3 		$58.1K Buy
22,422
+734
+3% +$2.58K ﹤0.01% 3621
2023
Q2 		$85.5K Sell
21,688
-3,131
-13% -$9.93K ﹤0.01% 3386
2023
Q1 		$83.9K Buy
+24,819
New +$101K ﹤0.01% 3003
2022
Q2 		– Sell
-97,319
Closed -$826K – 2893
2022
Q1 		$826K Buy
+97,319
New +$684K ﹤0.01% 1702
2021
Q4 		– Sell
-13,713
Closed -$143K – 3170
2021
Q3 		$143K Buy
+13,713
New +$120K ﹤0.01% 2596

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint's SRTA Position: Q1 2026 in Review

Squarepoint sold out of Strata Critical Medical Inc (SRTA) in Q1 2026, closing a stake of 92,013 shares — an estimated $443K sold.

Squarepoint first reported a position in SRTA in Q3 2021 and held it in 12 quarters. The position peaked at $1.97M in Q3 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Squarepoint reported no remaining Strata Critical Medical Inc position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 92,013 Strata Critical Medical Inc shares in Q1 2026, an estimated $443K.
  • Squarepoint first reported a position in Strata Critical Medical Inc in Q3 2021 and held it in 12 quarters.
  • Squarepoint's Strata Critical Medical Inc position peaked at $1.97M in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.